Proof of Concept: Trans-atrial AngioVac Aspiration of Mitral Valve Thrombosis in a COVID-19 Patient

ASAIO J. 2023 Jul 1;69(7):e342-e345. doi: 10.1097/MAT.0000000000001910. Epub 2023 Apr 4.

Abstract

In patients with a prohibitive surgical risk, the AngioVac cannula can be used to remove left-sided cardiac masses, as an off-label adaptation of the device. We herein describe a novel micro-invasive approach to gain access to the left atrium for the aspiration of a mitral valve mass in a patient affected by severe coronavirus disease 2019. Through a right anterior mini-thoracotomy, the right superior pulmonary vein was accessed and used to insert the aspiration cannula. A parallel venous-arterial extracorporeal membrane oxygenation (ECMO)-like circuit provided circulatory and respiratory support to ensure proper intra- and postoperative hemodynamic stabilization.

MeSH terms

  • Atrial Fibrillation*
  • COVID-19* / complications
  • Heart Atria / surgery
  • Humans
  • Mitral Valve / surgery
  • Thrombosis* / etiology
  • Thrombosis* / surgery